DK0724433T3 - Fremgangsmåde til fremstilling af mikrosfærer med et tørringstrin i fluidiseret leje - Google Patents

Fremgangsmåde til fremstilling af mikrosfærer med et tørringstrin i fluidiseret leje

Info

Publication number
DK0724433T3
DK0724433T3 DK94931369T DK94931369T DK0724433T3 DK 0724433 T3 DK0724433 T3 DK 0724433T3 DK 94931369 T DK94931369 T DK 94931369T DK 94931369 T DK94931369 T DK 94931369T DK 0724433 T3 DK0724433 T3 DK 0724433T3
Authority
DK
Denmark
Prior art keywords
fluidized bed
drying step
bed drying
preparing microspheres
microspheres
Prior art date
Application number
DK94931369T
Other languages
Danish (da)
English (en)
Inventor
Jeffrey L Cleland
Andrew J Jones
Michael Frank Powell
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of DK0724433T3 publication Critical patent/DK0724433T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK94931369T 1993-10-22 1994-10-13 Fremgangsmåde til fremstilling af mikrosfærer med et tørringstrin i fluidiseret leje DK0724433T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14225793A 1993-10-22 1993-10-22
US14331393A 1993-10-25 1993-10-25
PCT/US1994/011678 WO1995011009A1 (fr) 1993-10-22 1994-10-13 Procede de preparation de microspheres avec etape de sechage en lit fluidise

Publications (1)

Publication Number Publication Date
DK0724433T3 true DK0724433T3 (da) 1999-08-30

Family

ID=26839915

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94931369T DK0724433T3 (da) 1993-10-22 1994-10-13 Fremgangsmåde til fremstilling af mikrosfærer med et tørringstrin i fluidiseret leje

Country Status (9)

Country Link
EP (1) EP0724433B1 (fr)
JP (1) JP3841309B2 (fr)
AT (1) ATE175110T1 (fr)
AU (1) AU8017494A (fr)
CA (1) CA2172508C (fr)
DE (1) DE69415684T2 (fr)
DK (1) DK0724433T3 (fr)
UY (1) UY23846A1 (fr)
WO (1) WO1995011009A1 (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU685784B2 (en) * 1993-02-23 1998-01-29 Genentech Inc. Excipient stabilization of polypeptides treated with organic solvents
CN1074923C (zh) 1993-11-19 2001-11-21 詹森药业有限公司 微囊密封的3-哌啶基取代的1,2-苯并异唑类和1,2-苯并异噻唑类
US6117455A (en) * 1994-09-30 2000-09-12 Takeda Chemical Industries, Ltd. Sustained-release microcapsule of amorphous water-soluble pharmaceutical active agent
US6685940B2 (en) 1995-07-27 2004-02-03 Genentech, Inc. Protein formulation
US6267958B1 (en) 1995-07-27 2001-07-31 Genentech, Inc. Protein formulation
EP0765660A3 (fr) * 1995-09-28 1998-09-23 Takeda Chemical Industries, Ltd. Microcapsules contenant des acides 2-pipérazinone-1-yl-acétiques
US6270795B1 (en) 1995-11-09 2001-08-07 Microbiological Research Authority Method of making microencapsulated DNA for vaccination and gene therapy
DE69608122T3 (de) 1995-11-09 2011-06-16 Microbiological Research Authority Camr, Salisbury Mikroverkapselte dna zur impfung und gentherapie
DE19545257A1 (de) * 1995-11-24 1997-06-19 Schering Ag Verfahren zur Herstellung von morphologisch einheitlichen Mikrokapseln sowie nach diesem Verfahren hergestellte Mikrokapseln
GB2310801A (en) * 1996-03-04 1997-09-10 Merck & Co Inc Process for removing an organic solvent from lactide-glycoside copolymer microspheres
US6190702B1 (en) 1996-03-28 2001-02-20 Takeda Chemical Industries, Ltd. Sustained-released material prepared by dispersing a lyophilized polypeptide in an oil phase
ATE357218T1 (de) * 1996-05-07 2007-04-15 Alkermes Inc Micropartikel
CA2302522C (fr) * 1997-08-29 2010-08-17 Antigenics Llc Compositions renfermant l'adjuvant qs-21 et du polysorbate ou de la cyclodextrine comme excipient
AU1384199A (en) * 1997-11-07 1999-05-31 Chiron Corporation Method for producing igf-1 sustained-release formulations
SE9801288D0 (sv) 1998-04-14 1998-04-14 Astra Ab Vaccine delivery system and metod of production
GB9810236D0 (en) 1998-05-13 1998-07-08 Microbiological Res Authority Improvements relating to encapsulation of bioactive agents
AU1226901A (en) * 1999-10-22 2001-05-08 Amgen, Inc. Biodegradable microparticles with novel erythropoietin stimulating protein
US20090104274A1 (en) * 2005-03-01 2009-04-23 Ajay Khopade Process of making microspheres
WO2015161139A1 (fr) 2014-04-16 2015-10-22 Rapamycin Holdings, Llc Préparation orale de rapamycine et utilisation pour une stomatite
CA2784287C (fr) 2009-12-22 2017-07-18 Evonik Degussa Corporation Procede a base d'emulsion pour preparer des microparticules et ensemble d'unite de travail destinee a etre utilisee dans le procede
UA111162C2 (uk) 2010-08-04 2016-04-11 Флекшен Терап'Ютікс, Інк. Ін'єкційна композиція ацетоніду триамцинолону для лікування болю
EP2739287B1 (fr) * 2011-08-04 2017-07-05 Flexion Therapeutics, Inc. Corticostéroïdes destinés à traiter une douleur articulaire
EP3089737B1 (fr) 2013-12-31 2021-11-03 Rapamycin Holdings, LLC Préparations orales de nanoparticules de rapamycine, et utilisation
WO2023277051A1 (fr) * 2021-06-30 2023-01-05 国立大学法人大阪大学 Adjuvant

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
IT1214629B (it) * 1985-08-29 1990-01-18 Formenti Farmaceutici Spa Procedimento di microincapsulazione di un medicamento,medicamento cosi'preparato,e composizioni farmaceutiche che lo comprendono
US5075109A (en) * 1986-10-24 1991-12-24 Southern Research Institute Method of potentiating an immune response
IL84167A (en) * 1986-10-24 1991-04-15 Southern Res Inst Oral delivery of bioactive agents to and through the peyer's patch by use of microencapsulation
JP2813630B2 (ja) * 1987-02-20 1998-10-22 ジェネンテク，インコーポレイテッド ヒト免疫不全ウイルスのエンベロープポリペプチドおよびその抗体
EP0279688B1 (fr) * 1987-02-20 1997-04-16 Genentech, Inc. Méthodes et compositions pour l'utilisation de polypeptides env et anticorps anti-env de HIV
NO176278C (no) * 1988-08-24 1995-03-08 Allied Colloids Ltd Fremgangsmåte for fremstilling av en partikkelformig blanding av aktiv bestanddel i et polymert materiale
US5008116A (en) * 1988-11-14 1991-04-16 Frederick Cahn Immunostimulatory microsphere
US4990336A (en) * 1989-02-08 1991-02-05 Biosearch, Inc. Sustained release dosage form
US5126147A (en) * 1990-02-08 1992-06-30 Biosearch, Inc. Sustained release dosage form
FR2658432B1 (fr) * 1990-02-22 1994-07-01 Medgenix Group Sa Microspheres pour la liberation controlee des substances hydrosolubles et procede de preparation.
AU8303691A (en) * 1991-04-24 1992-12-21 United States Of America, As Represented By The Secretary Of The Army, The Oral-intestinal vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres
US5429822A (en) * 1992-03-13 1995-07-04 Cambridge Scientific, Inc. Biodegradable bursting release system
FR2703927B1 (fr) * 1993-04-13 1995-07-13 Coletica Utilisation d'une réaction de transacylation entre un polysaccharide estérifié et une polyamine pour former en milieu aqueux une membrane au moins en surface de particules gélifiées.
DE69431404T2 (de) * 1993-10-22 2003-04-30 Genentech Inc., San Francisco Verfahren zur mikroverkapselung von antigenen und verwendung der zusammensetzungen als impfstoffe
ATE223702T1 (de) * 1993-10-22 2002-09-15 Genentech Inc Verfahren und zusammensetzungen zur mikrokapselung von adjuvantien

Also Published As

Publication number Publication date
EP0724433B1 (fr) 1998-12-30
UY23846A1 (es) 1995-03-28
DE69415684T2 (de) 1999-06-10
DE69415684D1 (de) 1999-02-11
AU8017494A (en) 1995-05-08
JP3841309B2 (ja) 2006-11-01
CA2172508C (fr) 2005-08-23
JPH09504026A (ja) 1997-04-22
ATE175110T1 (de) 1999-01-15
CA2172508A1 (fr) 1995-04-27
EP0724433A1 (fr) 1996-08-07
WO1995011009A1 (fr) 1995-04-27

Similar Documents

Publication Publication Date Title
DK0724433T3 (da) Fremgangsmåde til fremstilling af mikrosfærer med et tørringstrin i fluidiseret leje
MX9201989A (es) Proceso para producir un componente magnetico compuesto, solido.
FI911386A7 (fi) Menetelmä säädettyjen tasakokoisten polymeerihiukkasten valmistamiseksi
DK0458162T3 (da) Proteinaseresistent cellulase, en mikroorganisme, der fremstiller samme, og fremgangsmåde til fremstilling af samme
DE68914773D1 (de) Verfahren zum Herstellen von teilchengefüllten mikroporösen Gegenständen.
HU914073D0 (en) New 5-chloro-quinoline-8-oxy-alkane-carboxylic acid derivatives, process for producing them and their utilization as antidote
FI940487L (fi) Vianmääritysmenetelmä kehitysprosessia varten
FI951497L (fi) Menetelmä kankaiden kivipesemiseksi endoglukanaaseja käyttäen
FI952407L (fi) Menetelmä absorboivan rakenteen valmistamiseksi sekä mainitulla menetelmällä valmistetun rakenteen sisältävä, absorboiva artikkeli
FI903114A7 (fi) Menetelmä kuivattujen hedelmien valmistamiseksi
FI925913L (fi) Menetelmä -olefiinien polymeroimiseksi sekä esipolymeroitu katalyyttikompositio ja menetelmä tämän valmistamiseksi
DK0417830T3 (da) Energibesparende fremgangsmåde til fremstilling af urea
FI894217L (fi) 1-adamantaanijohdannaisten valmistusmenetelmä
FI921428L (fi) Process foer enzymatisk framstaellning av en basisk fibroblastvaextfaktor.
NO176092C (no) Fremgangsmåte for omdanning av alifatiske C2 - C6-hydrocarboner til cycloalkaner
DK0634106T3 (da) Fremgangsmåde til behandling af vandopløselige kostfibre med beta-glucanase
DE69005048D1 (de) Matrix von Heteroübergang-Photodioden.
FI910573L (fi) Optisk fiberfoerstarkare, med dubbla kaerndelar, i vilken foerekommer ett brett signalvaoglaengsband.
FI913864L (fi) Produktionsprocess.
FI925497L (fi) Menetelmä synteettisten isohirudiinien valmistamiseksi, joilla on parantunut stabiilisuus
TR27902A (tr) Trifendioksazin bilesikleri, bunlarin üretilmesine mahsus usul ve bunlarin boyar madde olarak kullanilmasi.
DK0604060T3 (da) Fremgangsmåde til fremstilling af riboflavin
DE68911247D1 (de) Verfahren, um schlacke anzuzeigen.
FI903088A0 (fi) Process foer framstaellning av straengsprutade skumkroppar.
FI921103A7 (fi) Menetelmä oksamidin valmistamiseksi